Oxidative Stress Sensitizes Bladder Cancer Cells to TRAIL Mediated Apoptosis by Down-Regulating Anti-Apoptotic Proteins

Journal of Urology

Volumn 182, Issue 3, 2009, Pages 1178-1185

  White Gilbertson, Shai J ^a   Kasman, Laura ^a   McKillop, John ^a   Tirodkar, Tejas ^a   Lu, Ping ^a   Voelkel Johnson, Christina ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

apoptosis; oxidative stress; receptors; TNF related apoptosis inducing ligand; urinary bladder; urinary bladder neoplasms

Indexed keywords

APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN; CISPLATIN; DOXORUBICIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; HUMANS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; URINARY BLADDER NEOPLASMS;

EID: 68149157348     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.05.005     Document Type: Article

References (24)

1. Herr H.W., and Morales A. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol 179 (2008) 53
2. Simons M.P., O'Donnell M.A., and Griffith T.S. Role of neutrophils in BCG immunotherapy for bladder cancer. Urol Oncol 26 (2008) 341
3. Johnstone R.W., Frew A.J., and Smyth M.J. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 8 (2008) 782
4. Ashkenazi A., and Herbst R.S. To kill a tumor cell: the potential of proapoptotic receptor agonists. J Clin Invest 118 (2008) 1979
5. Jonsson G., Paulie S., and Grandien A. High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells. Anticancer Res 23 (2003) 1213
6. Kelly M.M., Hoel B.D., and Voelkel-Johnson C. Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression. Cancer Biol Ther 1 (2002) 520
7. White S.J., Kasman L.M., Kelly M.M., et al. Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2. Free Radic Biol Med 43 (2007) 1313
8. Kreuz S., Siegmund D., Scheurich P., et al. NF-kappa B inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21 (2001) 3964
9. White S.J., Lu P., Keller G.M., et al. Targeting the short form of cFLIP by RNA interference is sufficient to enhance TRAIL sensitivity in PC3 prostate carcinoma cells. Cancer Biol Ther 5 (2006) 1618
10. Mizutani Y., Yoshida O., Miki T., et al. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells. Clin Cancer Res 5 (1999) 2605
11. Jia L., Srinivasula S.M., Liu F.T., et al. Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood 98 (2001) 414
12. Koschny R., Walczak H., and Ganten T.M. The promise of TRAIL-potential and risks of a novel anticancer therapy. J Mol Med 85 (2007) 923
13. Koschny R., Ganten T.M., Sykora J., et al. TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. Hepatology 45 (2007) 649
14. Volkmann X., Fischer U., Bahr M.J., et al. Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver. Hepatology 46 (2007) 1498
15. Hempel N., Ye H., Abessi B., et al. Altered redox status accompanies progression to metastatic human bladder cancer. Free Radic Biol Med 46 (2009) 42
16. Dasgupta S., Hoque M.O., Upadhyay S., et al. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 68 (2008) 700
17. Okamoto M., Kawai K., Reznikoff C.A., et al. Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide. Cancer Res 56 (1996) 4649
18. Kong Q., Beel J.A., and Lillehei K.O. A threshold concept for cancer therapy. Med Hypotheses 55 (2000) 29
19. Ahmad I.M., Aykin-Burns N., Sim J.E., et al. Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem 280 (2005) 4254
20. Coyle C.H., Philips B.J., Morrisroe S.N., et al. Antioxidant effects of green tea and its polyphenols on bladder cells. Life Sci 83 (2008) 12
21. Loughlin K.R., Manson K., Cragnale D., et al. The use of hydrogen peroxide to enhance the efficacy of doxorubicin hydrochloride in a murine bladder tumor cell line. J Urol 165 (2001) 1300
22. Owsianowski E., Walter D., and Fahrenkrog B. Negative regulation of apoptosis in yeast. Biochim Biophys Acta 1783 (2008) 1303
23. Pineiro D., Gonzalez V.M., Hernandez-Jimenez M., et al. Translation regulation after taxol treatment in NIH3T3 cells involves the elongation factor (eEF)2. Exp Cell Res 313 (2007) 3694
24. Alexandroff A.B., Jackson A.M., O'Donnell M.A., et al. BCG immunotherapy of bladder cancer: 20 years on. Lancet 353 (1999) 1689